Roche Skin-cancer Drug Meets Trial Goals

Roche Holding said mid-stage trials of its experimental oral skin-cancer drug vismodegib showed the medicine to be successful in shrinking tumors in some patients.

Topics:  roche holding   trial   skin-cancer drug   
BING NEWS:
  • FDA Approves New Drug for Advanced Skin Cancer
    The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
    12/16/2024 - 7:49 am | View Link
  • FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
    Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.
    12/16/2024 - 12:22 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News